vs
Side-by-side financial comparison of Cipher Mining Inc. (CIFR) and LIFECORE BIOMEDICAL, INC. \DE\ (LFCR). Click either name above to swap in a different company.
Cipher Mining Inc. is the larger business by last-quarter revenue ($59.7M vs $31.1M, roughly 1.9× LIFECORE BIOMEDICAL, INC. \DE\). LIFECORE BIOMEDICAL, INC. \DE\ runs the higher net margin — -32.1% vs -1229.6%, a 1197.5% gap on every dollar of revenue. On growth, Cipher Mining Inc. posted the faster year-over-year revenue change (41.4% vs -4.5%). LIFECORE BIOMEDICAL, INC. \DE\ produced more free cash flow last quarter ($25.0K vs $-695.9M). Over the past eight quarters, Cipher Mining Inc.'s revenue compounded faster (11.4% CAGR vs -0.1%).
Cipher Mining, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business.
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
CIFR vs LFCR — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $59.7M | $31.1M |
| Net Profit | $-734.2M | $-10.0M |
| Gross Margin | 59.4% | 25.0% |
| Operating Margin | -503.4% | -9.9% |
| Net Margin | -1229.6% | -32.1% |
| Revenue YoY | 41.4% | -4.5% |
| Net Profit YoY | -4293.1% | -52.0% |
| EPS (diluted) | $-1.91 | $-0.29 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $59.7M | — | ||
| Q3 25 | $71.7M | $31.1M | ||
| Q2 25 | $43.6M | — | ||
| Q1 25 | $49.0M | $35.2M | ||
| Q4 24 | $42.2M | $32.6M | ||
| Q3 24 | $24.1M | $24.7M | ||
| Q2 24 | $36.8M | — | ||
| Q1 24 | $48.1M | $35.7M |
| Q4 25 | $-734.2M | — | ||
| Q3 25 | $-3.3M | $-10.0M | ||
| Q2 25 | $-45.8M | — | ||
| Q1 25 | $-39.0M | $-14.8M | ||
| Q4 24 | $17.5M | $-6.6M | ||
| Q3 24 | $-86.8M | $-16.2M | ||
| Q2 24 | $-15.3M | — | ||
| Q1 24 | $39.9M | $15.6M |
| Q4 25 | 59.4% | — | ||
| Q3 25 | 62.7% | 25.0% | ||
| Q2 25 | 64.8% | — | ||
| Q1 25 | 69.6% | 28.0% | ||
| Q4 24 | 56.9% | 34.0% | ||
| Q3 24 | 37.5% | 21.8% | ||
| Q2 24 | 61.2% | — | ||
| Q1 24 | 69.2% | 33.3% |
| Q4 25 | -503.4% | — | ||
| Q3 25 | -52.5% | -9.9% | ||
| Q2 25 | -103.9% | — | ||
| Q1 25 | -77.8% | -25.7% | ||
| Q4 24 | 40.5% | -6.0% | ||
| Q3 24 | -379.2% | -46.9% | ||
| Q2 24 | -43.9% | — | ||
| Q1 24 | 97.2% | -2.5% |
| Q4 25 | -1229.6% | — | ||
| Q3 25 | -4.6% | -32.1% | ||
| Q2 25 | -105.1% | — | ||
| Q1 25 | -79.6% | -42.0% | ||
| Q4 24 | 41.5% | -20.2% | ||
| Q3 24 | -359.9% | -65.7% | ||
| Q2 24 | -41.5% | — | ||
| Q1 24 | 82.9% | 43.8% |
| Q4 25 | $-1.91 | — | ||
| Q3 25 | $-0.01 | $-0.29 | ||
| Q2 25 | $-0.12 | — | ||
| Q1 25 | $-0.11 | $-0.47 | ||
| Q4 24 | $0.04 | $-0.25 | ||
| Q3 24 | $-0.26 | $-0.53 | ||
| Q2 24 | $-0.05 | — | ||
| Q1 24 | $0.13 | $0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $628.3M | $18.9M |
| Total DebtLower is stronger | $2.7B | $136.0M |
| Stockholders' EquityBook value | $805.5M | $-10.5M |
| Total Assets | $4.3B | $235.2M |
| Debt / EquityLower = less leverage | 3.37× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $628.3M | — | ||
| Q3 25 | $1.2B | $18.9M | ||
| Q2 25 | $62.7M | — | ||
| Q1 25 | $23.2M | $5.4M | ||
| Q4 24 | $5.6M | $9.5M | ||
| Q3 24 | $25.3M | — | ||
| Q2 24 | $122.6M | — | ||
| Q1 24 | $88.7M | — |
| Q4 25 | $2.7B | — | ||
| Q3 25 | $1.0B | $136.0M | ||
| Q2 25 | $167.1M | — | ||
| Q1 25 | — | $124.9M | ||
| Q4 24 | $0 | $111.3M | ||
| Q3 24 | — | $106.3M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $97.1M |
| Q4 25 | $805.5M | — | ||
| Q3 25 | $783.2M | $-10.5M | ||
| Q2 25 | $748.9M | — | ||
| Q1 25 | $734.8M | $2.2M | ||
| Q4 24 | $682.0M | $15.4M | ||
| Q3 24 | $672.0M | $-3.9M | ||
| Q2 24 | $690.8M | — | ||
| Q1 24 | $600.9M | $17.7M |
| Q4 25 | $4.3B | — | ||
| Q3 25 | $2.8B | $235.2M | ||
| Q2 25 | $1.0B | — | ||
| Q1 25 | $913.8M | $237.7M | ||
| Q4 24 | $855.4M | $255.4M | ||
| Q3 24 | $775.4M | $246.8M | ||
| Q2 24 | $775.6M | — | ||
| Q1 24 | $677.1M | $246.2M |
| Q4 25 | 3.37× | — | ||
| Q3 25 | 1.31× | — | ||
| Q2 25 | 0.22× | — | ||
| Q1 25 | — | 56.05× | ||
| Q4 24 | 0.00× | 7.20× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 5.49× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-207.9M | $1.8M |
| Free Cash FlowOCF − Capex | $-695.9M | $25.0K |
| FCF MarginFCF / Revenue | -1165.4% | 0.1% |
| Capex IntensityCapex / Revenue | 817.1% | 5.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-1.1B | $-16.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-207.9M | — | ||
| Q3 25 | $-50.1M | $1.8M | ||
| Q2 25 | $-56.2M | — | ||
| Q1 25 | $-47.2M | $1.2M | ||
| Q4 24 | $-87.5M | $-6.1M | ||
| Q3 24 | $-6.5M | $-613.0K | ||
| Q2 24 | $-25.4M | — | ||
| Q1 24 | $-26.6M | $-1.4M |
| Q4 25 | $-695.9M | — | ||
| Q3 25 | $-256.2M | $25.0K | ||
| Q2 25 | $-87.5M | — | ||
| Q1 25 | $-71.8M | $-4.3M | ||
| Q4 24 | $-227.0M | $-8.6M | ||
| Q3 24 | $-83.2M | $-4.0M | ||
| Q2 24 | $-33.2M | — | ||
| Q1 24 | $-34.5M | $-7.8M |
| Q4 25 | -1165.4% | — | ||
| Q3 25 | -357.3% | 0.1% | ||
| Q2 25 | -200.9% | — | ||
| Q1 25 | -146.7% | -12.1% | ||
| Q4 24 | -537.6% | -26.3% | ||
| Q3 24 | -345.0% | -16.3% | ||
| Q2 24 | -90.2% | — | ||
| Q1 24 | -71.7% | -21.8% |
| Q4 25 | 817.1% | — | ||
| Q3 25 | 287.5% | 5.6% | ||
| Q2 25 | 71.8% | — | ||
| Q1 25 | 50.2% | 15.5% | ||
| Q4 24 | 330.4% | 7.5% | ||
| Q3 24 | 317.8% | 13.9% | ||
| Q2 24 | 21.4% | — | ||
| Q1 24 | 16.4% | 17.8% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -5.00× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -0.67× | -0.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CIFR
Segment breakdown not available.
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
